"This further agreement will provide more people access to the natural therapeutic benefits of the supplement,” said managing director Roby Zomer ArtemiC has proven itself in a phase II clinical trial ...
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...
ASX-listed MGC Pharmaceuticals continues to spread its wings, signing an agreement with Germany’s Mexacare for the distribution of the company’s medical cannabis products to Germany, Austria and ...
A joint venture controlled by Russian billionaire Vladimir Potanin has acquired a 25% stake in IT infrastructure provider Selectel, one of the venture's partners said on Monday, as Moscow seeks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results